Engineering and Development

Management and Executive

Legal and Compliance

Customer Service and Support

Chief Financial Officer

Senior Vice President CMC Development

Alnylam Announces First Patient Dosed in ZENITH Global Phase 3 Cardiovascular Outcomes Trial of Zilebesiran

New HELIOS-B data show reduced gastrointestinal events with vutrisiran

Investors left reading tea leaves

New data from Helios-B Phase 3 study demonstrate lower rates of gastrointestinal events in ATTR-CM patients treated with Vutrisiran

Senior Director, Clinical Portfolio Technology

Alnylam Pharmaceuticals is a leader in RNAi therapeutics, seeking a strategic technology leader to drive the strategy, delivery, and governance of platforms supporting Clinical Delivery, Portfolio Management, and Data Science. The Senior Director will partner closely with various teams to enhance clinical trial execution and optimize portfolio analytics, thereby delivering measurable business impact.

Vice President, Study Management

Director Clinical Research

Associate Director Clinical Trial Oversight

Director, Clinical Research

Director of Clinical Portfolio Services - Systems

Sign up with Google

Sign in with Google